Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Perception of bronchoconstriction: a complementary disease marker in children with asthma.

Nuijsink M, Hop WC, Jongste JC, Sterk PJ, Duiverman AE; Cato Study Group..

J Asthma. 2013 Aug;50(6):560-4. doi: 10.3109/02770903.2013.792347. Epub 2013 May 20.

PMID:
23672570
2.

Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma.

Ottanelli R, Rosi E, Romagnoli I, Ronchi MC, Lanini B, Grazzini M, Filippelli M, Stendardi L, Duranti R, Scano G.

Clin Sci (Lond). 2000 Jun;98(6):681-7.

PMID:
10814605
3.

Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial.

Nuijsink M, Hop WC, Sterk PJ, Duiverman EJ, de Jongste JC.

Eur Respir J. 2007 Sep;30(3):457-66. Epub 2007 May 30.

4.

Effects of obesity on perceptual and mechanical responses to bronchoconstriction in asthma.

Deesomchok A, Fisher T, Webb KA, Ora J, Lam YM, Lougheed MD, O'Donnell DE.

Am J Respir Crit Care Med. 2010 Jan 15;181(2):125-33. doi: 10.1164/rccm.200906-0934OC. Epub 2009 Nov 12.

PMID:
19910609
5.

Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.

Bijl-Hofland ID, Cloosterman SG, Folgering HT, van den Elshout FJ, van Weel C, van Schayck CP.

Am J Respir Crit Care Med. 2001 Sep 1;164(5):764-9.

PMID:
11549530
6.
7.

Perception of dyspnea during acetylcholine-induced bronchoconstriction in asthmatic children.

Motomura C, Odajima H, Tezuka J, Harada J, Okada K, Nishima S.

Ann Allergy Asthma Immunol. 2009 Feb;102(2):121-4. doi: 10.1016/S1081-1206(10)60241-4.

PMID:
19230462
8.

Effect of budesonide on the perception of induced airway narrowing in subjects with asthma.

Salome CM, Reddel HK, Ware SI, Roberts AM, Jenkins CR, Marks GB, Woolcock AJ.

Am J Respir Crit Care Med. 2002 Jan 1;165(1):15-21.

PMID:
11779724
9.

Potential masking effect on dyspnoea perception by short- and long-acting beta2-agonists in asthma.

van Schayck CP, Bijl-Hofland ID, Cloosterman SG, Folgering HT, van der Elshout FJ, Van Weel C.

Eur Respir J. 2002 Feb;19(2):240-5.

10.

Lung hyperinflation, perception of bronchoconstriction and airway hyperresponsiveness.

Boulet LP, Turcotte H.

Clin Invest Med. 2007;30(1):2-11.

PMID:
17716534
11.

Perception of bronchoconstriction in obstructive pulmonary diseases (disease-specific dyspnoea).

Ekici A, Yilmaz S, Ekici M, Kalpaklioğlu F, Karadeniz Y, Arslan M, Iteginli A, Kara T, Kurtipek E.

Clin Sci (Lond). 2003 Aug;105(2):181-5.

PMID:
12667136
12.

Relation of the perception of airway obstruction to the severity of asthma.

Bijl-Hofland ID, Cloosterman SG, Folgering HT, Akkermans RP, van Schayck CP.

Thorax. 1999 Jan;54(1):15-19.

13.

Perception of bronchoconstriction in smokers with airflow limitation.

Ottanelli R, Rosi E, Ronchi MC, Grazzini M, Lanini B, Stendardi L, Romagnoli I, Bertini S, Duranti R, Scano G.

Clin Sci (Lond). 2001 Nov;101(5):515-22.

PMID:
11672457
14.

Increased perception of airway narrowing in patients with mild asthma.

James AL, Carroll N, De Klerk N, Elliott J, Musk AW, Ryan G.

Respirology. 1998 Dec;3(4):241-5.

PMID:
10201050
15.

Perception of acute airway function changes by patients with mild asthma.

Malakauskas K, Ragaisiene S, Sakalauskas R.

Allergy Asthma Proc. 2009 May-Jun;30(3):277-83. doi: 10.2500/aap.2009.30.3233. Erratum in: Allergy Asthma Proc. 2009 Sep-Oct;30(5):565. Sakalauskas, Rainundas [corrected to Sakalauskas, Raimundas].

PMID:
19549429
16.
17.

Perception of bronchoconstriction in chronic asthma.

Boner AL, De Stefano G, Piacentini GL, Bonizzato C, Sette L, Banfi F, Hindi-Alexander MC.

J Asthma. 1992;29(5):323-30.

PMID:
1522053
18.

Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists.

van der Woude HJ, Aalbers R.

Eur Respir J. 2001 Aug;18(2):269-71.

19.

[Asthma patients' perception of dyspnea during acute bronchoconstriction].

Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez-Francés ME.

Arch Bronconeumol. 2003 Feb;39(2):67-73. Spanish.

20.

Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.

FitzGerald JM, Chapman KR, Della Cioppa G, Stubbing D, Fairbarn MS, Till MD, Brambilla R.

J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):427-35.

PMID:
10069876

Supplemental Content

Support Center